- Home
- BMR vs NVNO Comparison
BMR vs NVNO Comparison
Compare BMR & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- NVNO
- Stock Information
- Founded
- BMR 2009
- NVNO 1987
- Country
- BMR Israel
- NVNO United States
- Employees
- BMR N/A
- NVNO N/A
- Industry
- BMR Computer Software: Prepackaged Software
- NVNO Medical/Dental Instruments
- Sector
- BMR Technology
- NVNO Health Care
- Exchange
- BMR Nasdaq
- NVNO Nasdaq
- Market Cap
- BMR 59.3M
- NVNO 71.0M
- IPO Year
- BMR 2023
- NVNO N/A
- Fundamental
- Price
- BMR $3.35
- NVNO $4.10
- Analyst Decision
- BMR
- NVNO
- Analyst Count
- BMR 0
- NVNO 0
- Target Price
- BMR N/A
- NVNO N/A
- AVG Volume (30 Days)
- BMR 1.0M
- NVNO 145.2K
- Earning Date
- BMR 08-05-2025
- NVNO 07-30-2025
- Dividend Yield
- BMR N/A
- NVNO N/A
- EPS Growth
- BMR N/A
- NVNO N/A
- EPS
- BMR N/A
- NVNO N/A
- Revenue
- BMR $3,064,000.00
- NVNO N/A
- Revenue This Year
- BMR $21.21
- NVNO N/A
- Revenue Next Year
- BMR N/A
- NVNO N/A
- P/E Ratio
- BMR N/A
- NVNO N/A
- Revenue Growth
- BMR 5.33
- NVNO N/A
- 52 Week Low
- BMR $1.86
- NVNO $2.03
- 52 Week High
- BMR $6.59
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- BMR 59.12
- NVNO 51.11
- Support Level
- BMR $2.98
- NVNO $3.90
- Resistance Level
- BMR $3.20
- NVNO $4.06
- Average True Range (ATR)
- BMR 0.22
- NVNO 0.26
- MACD
- BMR -0.01
- NVNO -0.06
- Stochastic Oscillator
- BMR 88.33
- NVNO 19.61
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.